Table 1 Outline of baseline characteristics for complete cohort
All patients | |
|---|---|
# of eyes | 101 |
Age (median, range) | 50 (24–76) |
Follow up time in months (mean–range) | 10 (5–36) |
Gender | 73% male |
27% female | |
% of patient with systemic medication (eplerenone/spironolactone, 25 mg daily) | 26% |
Diagnosis | |
Acute CSCR | 3 (3%) |
Chronic | 50 (50%) |
Persistent | 31 (30%) |
Recurrent | 17 (17%) |
BCVA in logMar (mean, SD) | 0.35 ± 0.3 |
CRT in µm (mean, SD) | 325 ± 130 |
Type of leakage | |
Diffuse | 58 (57%) |
Focal | 43 (43%) |